Conditions: Incidental Gallbladder Carcinoma; Biliary Tract Cancer
Interventions: Drug: Gemcitabine; Drug: Cisplatin; Procedure: Oncologically radical margin-free (R0) resection; Drug: Adjuvant chemotherapy
Sponsors: Krankenhaus Nordwest; German Research Foundation
Not yet recruiting
Feeds
3707 items (3707 unread) in 74 feeds
Acinar Cell Carcinoma
(20 unread)
Acinic Cell Carcinoma
(15 unread)
Adenoid Cystic Carcinoma
(52 unread)
Adrenal Gland Cancer
(234 unread)
Ampulla Of Vater
(18 unread)
Anal Cancer
(422 unread)
Angiosarcoma
(46 unread)
Appendix Cancer
(39 unread)
Bile Duct Cancer
(435 unread)
Brain and CNS
(581 unread)
Carcinoid
(111 unread)
Endocrine/Neuroendocrine
(487 unread)
Gall Bladder Cancer
(83 unread)
Hemangioendothelioma
(29 unread)
Hepatoblastoma
(40 unread)
Pancreas
(29 unread)
Phyllodes
(34 unread)
PMP and Mucinous Tumors
(11 unread)
Rhabdomyosarcoma
(87 unread)
Sarcoma
(934 unread)
Trials - Gall Bladder Cancer (10 unread)
-
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy
Posted: September 17th, 2018, 2:00pm GMT
-
Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos
Posted: September 12th, 2018, 2:00pm GMT
Conditions: Liver Cancer; Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Colo-rectal Cancer; Gall Bladder Cancer; Biliary Tract Cancer
Interventions: Drug: Fluorouracil; Drug: Lederfolin; Drug: Oxaliplatin; Drug: Irinotecan; Drug: Docetaxel; Drug: Cisplatin; Drug: Epirubicin; Drug: Gemcitabine; Drug: Nab paclitaxel
Sponsors: University of Pisa; Azienda Ospedaliero, Universitaria Pisana
Recruiting -
The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Posted: August 20th, 2018, 2:00pm GMT
Conditions: Pancreas Cancer; Cholangiocarcinoma; Gallbladder Cancer
Intervention: Other: Measurement of triceps skinfold thickness
Sponsor: Samsung Medical Center
Recruiting -
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Posted: July 31st, 2018, 2:00pm GMT
Conditions: Cancer of Pancreas; Cancer of Liver; Cancer of Rectum; Cancer of Colon; Cancer, Gall Bladder; Myeloma Multiple; Glioblastoma Multiforme
Interventions: Drug: Cannabidiol; Drug: Bortezomib; Drug: Leucovorin; Drug: 5-FU; Drug: Oxaliplatin; Drug: Bevacizumab; Drug: Irinotecan; Drug: Gemcitabine; Drug: Temozolomide
Sponsor: Leaf Vertical Inc.
Not yet recruiting -
Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS, and GEM; and CIS and GEM Alone in Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenoc
Posted: August 31st, 2017, 2:00pm GMT
Conditions: Cholangiocarcinoma Non-resectable; Cholangiocarcinoma, Intrahepatic; Cholangiocarcinoma, Extrahepatic; Gallbladder Adenocarcinoma
Interventions: Drug: PEGPH20; Drug: CIS; Drug: GEM; Drug: Atezolizumab
Sponsor: Halozyme Therapeutics
Recruiting -
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Posted: August 22nd, 2017, 2:00pm GMT
Conditions: Extrahepatic Bile Duct Adenocarcinoma, Biliary Type; Gallbladder Adenocarcinoma, Biliary Type; Metastatic Pancreatic Adenocarcinoma; Recurrent Cholangiocarcinoma; Recurrent Gallbladder Carcinoma; Recurrent Hepatocellular Carcinoma; Recurrent Intrahepatic Cholangiocarcinoma; Recurrent Pancreatic Carcinoma; Stage III Gallbladder Cancer AJCC V7; Stage III Hepatocellular Carcinoma AJCC v7; Stage III Intrahepatic Cholangiocarcinoma AJCC v7; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IIIA Gallbladder Cancer AJCC v7; Stage IIIA Hepatocellular Carcinoma AJCC v7; Stage IIIB Gallbladder Cancer AJCC v7; Stage IIIB Hepatocellular Carcinoma AJCC v7; Stage IIIC Hepatocellular Carcinoma AJCC v7; Stage IV Gallbladder Cancer AJCC v7; Stage IV Hepatocellular Carcinoma AJCC v7; Stage IV Pancreatic Cancer AJCC v6 and v7; Stage IVA Gallbladder Cancer AJCC v7; Stage IVA Hepatocellular Carcinoma AJCC v7; Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7; Stage IVB Gallbladder Cancer AJCC v7; Stage IVB Hepatocellular Carcinoma AJCC v7; Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7; Unresectable Gallbladder Carcinoma; Unresectable Pancreatic Carcinoma
Interventions: Biological: Durvalumab; Drug: Guadecitabine
Sponsors: University of Southern California; National Cancer Institute (NCI); Van Andel Research Institute
Recruiting -
Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer
Posted: July 27th, 2017, 2:00pm GMT
Condition: Biliary Tract Cancer
Interventions: Drug: Varlitinib; Drug: Capecitabine
Sponsor: Aslan Pharmaceuticals
Recruiting -
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
Posted: June 28th, 2017, 2:00pm GMT
Conditions: Gallbladder Carcinoma; Stage IV Intrahepatic Cholangiocarcinoma AJCC v8; Unresectable Cholangiocarcinoma
Interventions: Drug: Atezolizumab; Drug: Cobimetinib; Other: Laboratory Biomarker Analysis
Sponsor: National Cancer Institute (NCI)
Recruiting -
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Posted: March 28th, 2017, 2:00pm GMT
Condition: Biliary Tract Cancer
Interventions: Drug: Varlitinib; Drug: Capecitabine; Drug: Placebo (for Varlitinib)
Sponsor: Aslan Pharmaceuticals
Recruiting -
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Posted: March 11th, 2011, 3:00pm GMT
Conditions: Non-GI Cancers; Cancer of Gastrointestinal Tract; Gastrointestinal Cancer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting